scholarly journals Dipeptidyl Peptidase IV Inhibitor MK-0626 Attenuates Pancreatic Islet Injury in Tacrolimus-Induced Diabetic Rats

PLoS ONE ◽  
2014 ◽  
Vol 9 (6) ◽  
pp. e100798 ◽  
Author(s):  
Long Jin ◽  
Sun Woo Lim ◽  
Kyoung Chan Doh ◽  
Shang Guo Piao ◽  
Jian Jin ◽  
...  
2014 ◽  
Vol 33 (2) ◽  
pp. A6-A7
Author(s):  
Sun Woo Lim ◽  
Jin Long ◽  
Doh Kyoung Chan ◽  
Jin Jian ◽  
Piao Shang Guo ◽  
...  

2009 ◽  
Vol 61 (5) ◽  
pp. 899-908 ◽  
Author(s):  
Atsuo Tahara ◽  
Akiko Matsuyama-Yokono ◽  
Ryosuke Nakano ◽  
Yuka Someya ◽  
Masahiko Hayakawa ◽  
...  

Diabetes ◽  
2002 ◽  
Vol 51 (3) ◽  
pp. 652-661 ◽  
Author(s):  
S. A. Hinke ◽  
R. W. Gelling ◽  
R. A. Pederson ◽  
S. Manhart ◽  
C. Nian ◽  
...  

1993 ◽  
Vol 41 (1) ◽  
pp. 81-88 ◽  
Author(s):  
M D Poulsen ◽  
G H Hansen ◽  
E Dabelsteen ◽  
P E Høyer ◽  
O Norén ◽  
...  

Dipeptidyl peptidase IV (DP IV:EC 3.4.14.5) was localized in endocrine cells of pig pancreas by immunohistochemical and enzyme histochemical methods. Immunolight microscopy with both monoclonal and polyclonal antibodies demonstrated DP IV immunoreactivity in cells located in the peripheral part of the islets of Langerhans. The antigen is enzymatically active, as shown by enzyme histochemical analysis with a synthetic DP IV substrate. By immunoelectron microscopy (immunogold labeling), the labeling of DP IV in the islets was associated with the secretory granules of the A-cells, as identified by double labeling using a monoclonal glucagon antibody as the second primary antibody. These results show that DP IV is sorted to secretory granules in the pig pancreatic islet A-cells. Furthermore, this secretory granule enzyme, as opposed to intestinal brush border DP IV, is suggested to be a soluble protein, since the gold particles appear all over the granules and are not specifically associated with the granule membrane.


2011 ◽  
Vol 340 (2) ◽  
pp. 248-255 ◽  
Author(s):  
Wei Jing Liu ◽  
Shu Hua Xie ◽  
Yu Ning Liu ◽  
Won Kim ◽  
Heung Yong Jin ◽  
...  

2015 ◽  
Vol 6 (6) ◽  
pp. 1887-1892 ◽  
Author(s):  
C. H. Hsieh ◽  
T. Y. Wang ◽  
C. C. Hung ◽  
M. C. Chen ◽  
K. C. Hsu

FSGH has the function of inhibiting GLP-1 degradation by DPP-IV, resulting in the enhancement of insulin secretion and improvement of glycemic control in STZ-induced diabetic rats.


Diabetes ◽  
2003 ◽  
Vol 52 (3) ◽  
pp. 741-750 ◽  
Author(s):  
J. A. Pospisilik ◽  
J. Martin ◽  
T. Doty ◽  
J. A. Ehses ◽  
N. Pamir ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document